Recombinant IL6 (Clazakizumab Biosimilar) antibody

Catalog No. ABIN7597591

The Humanized Chimeric anti-IL6 (Clazakizumab Biosimilar) antibody has been validated for . It is suitable to detect IL6 (Clazakizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL6 (Clazakizumab Biosimilar) antibody (ABIN7597591)

Target: IL6 (Clazakizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IL6 (Clazakizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL6 (Clazakizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Clazakizumab Biosimilar Antibody

Specificity: Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.55 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL6 (Clazakizumab Biosimilar)

Target: IL6 (Clazakizumab Biosimilar)

Alternative Name: Clazakizumab Biosimilar

Target Type: Biosimilar

Background: Hybridoma growth factor, BSF-2, IFN-beta-2, CDF, IL6, Interleukin-6, IL-6, B-cell stimulatory factor 2, Interferon beta-2, IFNB2, CTL differentiation factor

UniProt: P05231

CAS-No: 1236278-28-6